◆ A113 University Research Commercialization
From issued patent to defense program of record.
Universities hold thousands of issued patents whose research breakthroughs could solve named Department of War modernization priorities. A113's intelligence platform maps your portfolio against active federal programs, identifies the commercialization pathways, and accelerates the licensing outcomes that turn research into a program of record.
The Gap
The structural gap in defense technology transfer.
Universities issue more defense-relevant patents than the entire small business defense industrial base can absorb. The federal government funds research that produces breakthrough capability. Industry needs that capability to win program contracts. And yet the path from issued patent to commercial licensee to program-of-record remains one of the longest, least-instrumented processes in the U.S. innovation system.
The gap is not technical. The gap is connective. Knowing which patents map to which active appropriations line items, which Program Managers are funding those line items, which Prime contractors and small businesses are positioned to commercialize the technology, and which licensing structure aligns research interests with defense market realities — this is the work that determines whether university IP becomes a deployed capability or remains a paper grant.
What We Do
A new commercialization intelligence layer for your portfolio.
Portfolio Mapping to Federal Priorities
Every defense-relevant patent in your portfolio analyzed against the active Department of War budget — Program Elements, Budget Line Items, Congressional adds, justification text. See which research investments align with funded modernization priorities and which sit outside today's program of record landscape.
Named Licensee Identification
For each high-alignment patent, the platform identifies specific companies — primes, small businesses, and dual-use commercial firms — whose existing capabilities, contract revenue, and technology portfolios make them qualified licensees. The output is a ranked list with named introduction pathways.
Program Office and Sponsor Mapping
Identifies the federal Program Managers, contracting officers, and program offices funding the technology area. Surfaces the Congressional champions whose districts and committee positions intersect with the research. Translates your portfolio into the federal customer landscape that ultimately funds commercialization.
Commercialization Pathway Analysis
Each high-priority patent receives a recommended commercialization pathway: licensing to an established prime, partnership with an SBIR/STTR performer, dual-use commercial path, or strategic acquisition. Each pathway includes the named partner candidates and the federal funding mechanisms that support the transition.
Process
A structured engagement, calibrated to your portfolio.
Scope and onboard
We work with your office to define the scope of the engagement: the full defense-relevant portfolio, a specific research center, a strategic technology area, or a discrete set of patents under active commercialization. The onboarding phase aligns the scope of the analysis to your office's licensing priorities.
Run the intelligence layer
The platform ingests your portfolio, applies the federal-program matching engine across the active Department of War budget pipeline, and produces the ranked analysis. Patents are scored for federal alignment, named licensees are identified, program offices and Congressional sponsors are mapped, and commercialization pathways are recommended.
Deliver and engage
The deliverable is a structured analysis document — typically 30 to 60 pages — plus a working session with your licensing team. Where appropriate, A113 can facilitate introductions to identified licensees on your behalf, with terms aligned to your office's standard licensing practices.
Engagements
Two engagement structures.
Portfolio Analysis
A one-time, comprehensive analysis of your defense-relevant patent portfolio. Suitable as an annual deliverable for the licensing office, or as the input to a specific commercialization campaign.
- Full defense-relevant portfolio scoring
- Top 30 high-alignment patents identified
- Named potential licensees for each
- Program office and Congressional sponsor mapping
- Commercialization pathway recommendations
- 60-minute readout with the licensing team
Delivery
4 to 6 weeks
Annual Subscription
A live tenant relationship that turns A113 into an extension of your licensing office. Continuous portfolio refresh, quarterly licensee target review, and on-demand analysis for active licensing negotiations.
- Live tenant access to the platform
- Quarterly portfolio refresh and new-opportunity surfacing
- Monthly review session with the A113 team
- Named-licensee introduction support for top priorities
- Quarterly Congressional mark-up analysis affecting your research areas
- Federal program landscape briefings
Delivery
12-month minimum engagement
Pricing scoped to portfolio size and engagement depth. Most engagements fall between $35,000 and $90,000 annually. Contact us for a scoping conversation tailored to your office's licensing priorities.
Partners
Built for the offices that bridge research and the federal mission.
A113 partners with university Technology Licensing Offices, research foundations, applied research laboratories, and federally-funded research centers whose portfolios intersect with defense and national security modernization. Our engagement model respects the institutional norms of academic technology transfer — including standard royalty structures, inventor compensation practices, and Bayh-Dole compliance — while bringing the federal market intelligence that accelerates licensing outcomes.
About A113
Operators at the intersection of research, capital, and federal markets.
A113 Partners is an engineering and intelligence firm based in Dallas with operations in Washington and New York. The principal has founded and exited advanced technology companies — most recently a leader in two-phase liquid immersion cooling acquired by a Fortune 1000 industrial — and holds 25+ patents across robotics, post-quantum security, advanced batteries, and edge infrastructure. Our platform is built and operated by people who have done the commercialization work, not consulted on it from the outside.
FAQ
Common questions from licensing offices.
Let's discuss your portfolio.
A scoping conversation is the right first step. Thirty minutes, no commitment. We learn about your office's licensing priorities, the research areas where federal alignment matters most, and the specific portfolios where the platform's analysis would produce the most actionable output.